Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms

MT Newswires

05/12

Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.

Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.

Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the Singapore Exchange.

The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.

Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2634602265"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2634602265\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2634602265?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 12:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2634602265","market":"hk","top_or_hot":-1,"title":"Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms","media":"MT Newswires","content":"<html><body><p> Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.</p><p>Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.</p><p>Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the <a href=\"https://laohu8.com/S/S68.SI\">Singapore Exchange</a>.</p><p>The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.</p><p>Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time smaller\">2026-05-12 12:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.</p><p>Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.</p><p>Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the <a href=\"https://laohu8.com/S/S68.SI\">Singapore Exchange</a>.</p><p>The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.</p><p>Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6516","symbol_name":"銀行與投資服務概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2634602265","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2634602265","pubTimestamp":1778560004,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.Shares of the agrifood and med","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6516":"银行与投资服务概念","42T.SI":"趋势线","BK6052":"资产管理与托管银行"},"translate_title":"控股股东Trendlines将向投资组合公司投资总计140万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"42T.SI":0.9},"content_text":"Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the Singapore Exchange.The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}